The Name of the #1 Stock to Trade in 2021

From Legacy Research | Ad

Expert Jeff Clark is releasing his #1 stock to trade in 2021.

Since he started recommending this stock, you could have used it for gains as high as 269% and even 273%... in as little as 8 days.

Click here now and get its name.

BMRN Insider Trading (BioMarin Pharmaceutical)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.15%

Insider Buying (Last 12 Months): $1,001,728.00

Insider Selling (Last 12 Months): $30,851,118.91

BioMarin Pharmaceutical Insider Trading History Chart

BioMarin Pharmaceutical Share Price & Price History

^$77.77

▼ -0.84 (-1.07%)

As of 05/7/2021 01:00 AM ET

Days: 30 | 90 | 365

Former Congressman warns something BIG is coming

From Stansberry | Ad

There’s an important message that’s lost on anyone listening to the mainstream narrative right now. But serious signs of trouble are already starting to appear. And the long-term effects will be devastating. Find out in this new video what’s really going on. Then protect yourself and your family from what’s right around the corner.

Click Here To See Those Steps

BioMarin Pharmaceutical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/6/2021	Richard A Meier	Director	Sell	5,068	$78.38	$397,229.84	99,340
5/3/2021	George Eric Davis	EVP	Sell	4,673	$78.30	$365,895.90	68,781
4/23/2021	Jean Jacques Bienaime	CEO	Sell	10,000	$79.34	$793,400.00	312,498
4/19/2021	George Eric Davis	EVP	Sell	2,709	$79.58	$215,582.22	71,149
4/8/2021	Jeffrey Robert Ajer	EVP	Sell	1,537	$78.81	$121,130.97	58,250
4/1/2021	Brian Mueller	CFO	Sell	5,692	$76.30	$434,299.60	31,016
3/24/2021	Jeffrey Robert Ajer	EVP	Sell	1,181	$76.30	$90,110.30	61,439
3/18/2021	Jeffrey Robert Ajer	EVP	Sell	1,308	$77.99	$102,010.92	64,133
3/11/2021	Jean Jacques Bienaime	CEO	Sell	7,000	$77.68	$543,760.00	295,652
3/5/2021	Michael G Grey	Director	Sell	5,000	$76.28	$381,400.00	47,840
2/19/2021	Jean Jacques Bienaime	CEO	Sell	7,000	$83.58	$585,060.00	302,552
2/17/2021	Jean Jacques Bienaime	CEO	Sell	8,000	$84.54	$676,320.00	303,552
1/29/2021	Jean Jacques Bienaime	CEO	Sell	8,334	$82.67	$688,971.78	303,885
1/27/2021	Jean Jacques Bienaime	CEO	Sell	8,333	$85.49	$712,388.17	303,885
12/28/2020	Jean Jacques Bienaime	CEO	Sell	1,500	$88.77	$133,155.00	297,052
10/14/2020	Jeffrey Robert Ajer	EVP	Sell	2,121	$79.91	$169,489.11	61,281
8/31/2020	David E I Pyott	Director	Buy	12,800	$78.26	$1,001,728.00	29,840
8/3/2020	Michael G Grey	Director	Sell	2,500	$120.35	$300,875.00	45,340
7/20/2020	Henry J Fuchs	Insider	Sell	126,389	$130.00	$16,430,570.00	104,245
7/13/2020	Henry J Fuchs	Insider	Sell	23,011	$130.00	$2,991,430.00	102,995
6/26/2020	Willard H Dere	Director	Sell	4,430	$123.61	$547,592.30	13,290
6/19/2020	Jeffrey Robert Ajer	EVP	Sell	15,000	$124.00	$1,860,000.00	63,402
6/5/2020	V Bryan Lawlis	Director	Sell	4,430	$107.46	$476,047.80	18,850
5/8/2020	Jean Jacques Bienaime	CEO	Sell	20,000	$91.72	$1,834,400.00	318,552
5/4/2020	Jean Jacques Bienaime	CEO	Sell	5,000	$88.00	$440,000.00	298,552
5/1/2020	George Eric Davis	EVP	Sell	12,504	$89.38	$1,117,607.52	78,181
5/1/2020	Jean Jacques Bienaime	CEO	Sell	4,000	$89.38	$357,520.00	298,552
4/28/2020	Jean Jacques Bienaime	CEO	Sell	20,000	$97.58	$1,951,600.00	318,213
4/24/2020	Henry J Fuchs	Insider	Sell	20,000	$95.88	$1,917,600.00	109,014
4/20/2020	Henry J Fuchs	Insider	Sell	17,213	$90.00	$1,549,170.00	122,656
4/9/2020	Jean Jacques Bienaime	CEO	Sell	10,000	$79.06	$790,600.00	308,213
4/8/2020	Jeffrey Robert Ajer	EVP	Sell	2,407	$79.98	$192,511.86	63,064
4/1/2020	Jeffrey Robert Ajer	EVP	Sell	1,537	$82.00	$126,034.00	65,471
3/24/2020	Jeffrey Robert Ajer	EVP	Sell	2,041	$74.36	$151,768.76	68,626
3/17/2020	V Bryan Lawlis	Director	Sell	3,750	$75.39	$282,712.50	18,980
3/9/2020	Jean Jacques Bienaime	CEO	Sell	10,000	$89.52	$895,200.00	296,443
1/14/2020	Jean Jacques Bienaime	CEO	Sell	8,000	$87.95	$703,600.00	335,530
1/7/2020	Jean Jacques Bienaime	CEO	Sell	3,000	$84.46	$253,380.00	330,530
12/27/2019	Jean Jacques Bienaime	CEO	Sell	5,000	$86.16	$430,800.00
12/17/2019	V Bryan Lawlis	Director	Sell	3,750	$83.36	$312,600.00	27,340
11/26/2019	George Eric Davis	EVP	Sell	3,190	$79.66	$254,115.40	68,709
11/22/2019	Jean Jacques Bienaime	CEO	Sell	10,000	$77.60	$776,000.00	327,070
10/25/2019	Jean Jacques Bienaime	CEO	Sell	5,000	$69.55	$347,750.00	332,520
9/17/2019	V Bryan Lawlis	Director	Sell	3,750	$74.47	$279,262.50	27,340
6/17/2019	V Bryan Lawlis	Director	Sell	3,750	$81.08	$304,050.00	27,340
5/10/2019	Jean Jacques Bienaime	CEO	Sell	10,000	$82.52	$825,200.00	336,520
5/8/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$82.16	$328,640.00	326,520
4/26/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$82.88	$248,640.00	329,211
4/12/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$89.12	$356,480.00	325,211
4/8/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$91.87	$275,610.00	327,211
4/5/2019	Brian Mueller	SVP	Sell	2,953	$94.00	$277,582.00	13,660
4/5/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$93.37	$280,110.00	327,211
4/1/2019	Daniel K Spiegelman	CFO	Sell	13,473	$89.00	$1,199,097.00	47,510
3/27/2019	Daniel K Spiegelman	CFO	Sell	100	$90.00	$9,000.00	60,983
3/27/2019	V Bryan Lawlis	Director	Sell	2,150	$89.76	$192,984.00	21,310
3/25/2019	George Eric Davis	EVP	Sell	3,363	$87.86	$295,473.18	75,253
3/25/2019	Henry J Fuchs	Insider	Sell	5,932	$87.86	$521,185.52	130,468
3/25/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$87.86	$351,440.00	323,211
3/21/2019	Jeffrey Robert Ajer	EVP	Sell	4,519	$89.98	$406,619.62	56,659
3/19/2019	Jeffrey Robert Ajer	EVP	Sell	3,728	$93.07	$346,964.96	59,248
3/18/2019	Henry J Fuchs	Insider	Sell	9,597	$94.09	$902,981.73	133,061
3/15/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$94.40	$377,600.00	300,558
3/12/2019	Jean Jacques Bienaime	CEO	Sell	9,000	$90.06	$810,540.00	333,701
3/7/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$90.78	$363,120.00	332,701
3/4/2019	Henry J Fuchs	Insider	Sell	2,196	$95.00	$208,620.00	142,504
2/27/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$91.78	$367,120.00	292,290
2/21/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$90.12	$270,360.00	291,290
2/14/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$95.20	$380,800.00	292,290
2/5/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$98.63	$394,520.00	292,290
1/22/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$96.82	$290,460.00	291,290
1/14/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$93.79	$375,160.00	292,290
1/10/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$90.55	$271,650.00	291,290
1/7/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$87.58	$262,740.00	291,290
12/28/2018	Jean Jacques Bienaime	CEO	Sell	3,000	$84.04	$252,120.00
12/28/2018	Jean Jacques Bienaime	CEO	Sell	3,000	$84.04	$252,120.00	291,290
12/27/2018	V Bryan Lawlis	Director	Sell	2,150	$82.53	$177,439.50	21,310
12/26/2018	Jean Jacques Bienaime	CEO	Sell	4,000	$80.50	$322,000.00	292,290
12/14/2018	Jean Jacques Bienaime	CEO	Sell	2,000	$92.64	$185,280.00	290,290
12/12/2018	Jean Jacques Bienaime	CEO	Sell	2,000	$93.12	$186,240.00	290,290
11/14/2018	Jeffrey Robert Ajer	EVP	Sell	9,000	$92.15	$829,350.00	58,135
11/1/2018	Jean Jacques Bienaime	CEO	Sell	4,000	$92.55	$370,200.00	292,290
10/3/2018	Jean Jacques Bienaime	CEO	Sell	1,500	$99.36	$149,040.00	287,790
10/3/2018	Jeffrey Robert Ajer	EVP	Sell	1,000	$98.98	$98,980.00	49,135
9/27/2018	V Bryan Lawlis	Director	Sell	2,150	$97.93	$210,549.50	21,310
9/13/2018	George Eric Davis	EVP	Sell	12,000	$99.57	$1,194,840.00	74,950
9/13/2018	Richard A Meier	Director	Sell	3,000	$99.24	$297,720.00	81,610
9/5/2018	Elaine J Heron	Director	Sell	1,000	$96.94	$96,940.00	41,685
9/4/2018	Jean Jacques Bienaime	CEO	Sell	1,500	$98.16	$147,240.00	286,790
8/27/2018	Henry J Fuchs	Insider	Sell	25,000	$99.50	$2,487,500.00	142,667
8/27/2018	Richard A Meier	Director	Sell	2,000	$100.12	$200,240.00	69,610
8/24/2018	Henry J Fuchs	Insider	Sell	12,500	$99.00	$1,237,500.00	142,667
8/21/2018	Alan Lewis	Director	Sell	4,200	$100.09	$420,378.00	21,160
8/7/2018	Brian Mueller	SVP	Sell	2,500	$104.50	$261,250.00	14,093
8/7/2018	Robert Baffi	EVP	Sell	5,173	$105.00	$543,165.00	83,276
7/23/2018	Jean Jacques Bienaime	CEO	Sell	1,500	$101.69	$152,535.00	286,790
6/27/2018	V Bryan Lawlis	Director	Sell	2,150	$93.52	$201,068.00	21,310
6/22/2018	Brian Mueller	SVP	Sell	3,145	$99.50	$312,927.50	12,375
6/22/2018	Daniel K Spiegelman	CFO	Sell	10,000	$99.00	$990,000.00	51,542
6/22/2018	Robert Baffi	EVP	Sell	6,949	$99.00	$687,951.00	90,225
6/15/2018	Brian Mueller	SVP	Sell	2,021	$94.50	$190,984.50	13,029
6/14/2018	Henry J Fuchs	Insider	Sell	31,000	$90.00	$2,790,000.00	157,167
6/11/2018	Jeffrey Robert Ajer	EVP	Sell	1,436	$90.31	$129,685.16	50,135
5/17/2018	Jean Jacques Bienaime	CEO	Sell	18,750	$88.66	$1,662,375.00	309,350
5/15/2018	Jean Jacques Bienaime	CEO	Sell	37,500	$88.75	$3,328,125.00	309,350
5/11/2018	Jean Jacques Bienaime	CEO	Sell	18,750	$88.42	$1,657,875.00
5/10/2018	Brian Mueller	SVP	Sell	2,450	$89.50	$219,275.00	17,846
5/7/2018	Jeffrey Robert Ajer	EVP	Sell	309	$85.96	$26,561.64	53,223

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

97.65% of BioMarin Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioMarin Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/7/2021	Advisors Asset Management Inc.	19,715	$1.49M	0.0%	-7.8%	0.011%
5/7/2021	American International Group Inc.	3,876	$0.29M	0.0%	-10.5%	0.002%
5/7/2021	Cambridge Investment Research Advisors Inc.	9,598	$0.73M	0.0%	+76.3%	0.005%
5/7/2021	Mariner LLC	16,678	$1.26M	0.0%	-34.1%	0.009%
5/7/2021	Swiss National Bank	697,232	$52.65M	0.0%	+1.8%	0.382%
5/7/2021	IndexIQ Advisors LLC	2,889	$0.22M	0.0%	+14.5%	0.002%
5/7/2021	Clarus Group Inc.	100,000	$0.30M	0.1%	N/A	0.055%
5/7/2021	The PNC Financial Services Group Inc.	6,384	$0.48M	0.0%	-26.0%	0.003%
5/7/2021	Keybank National Association OH	159,771	$12.06M	0.1%	+144.0%	0.087%
5/7/2021	Nippon Life Global Investors Americas Inc.	221,860	$16.75M	0.9%	+3.6%	0.121%
5/7/2021	Altfest L J & Co. Inc.	6,146	$0.46M	0.1%	-7.5%	0.003%
5/7/2021	Kistler Tiffany Companies LLC	938	$71K	0.0%	+16.1%	0.001%
5/7/2021	Asahi Life Asset Management CO. LTD.	3,950	$0.30M	0.0%	N/A	0.002%
5/6/2021	Arizona State Retirement System	52,339	$3.95M	0.0%	+0.6%	0.029%
5/6/2021	Blueshift Asset Management LLC	10,455	$0.79M	0.1%	N/A	0.006%
5/6/2021	Rhumbline Advisers	192,187	$14.51M	0.0%	-5.8%	0.105%
5/6/2021	Quantitative Systematic Strategies LLC	8,000	$0.60M	0.1%	-35.3%	0.004%
5/6/2021	Parnassus Investments CA	2,684,874	$202.74M	0.5%	+76.8%	1.469%
5/6/2021	First National Trust Co	55,302	$4.18M	0.3%	N/A	0.030%
5/6/2021	Alliancebernstein L.P.	106,886	$8.07M	0.0%	-74.4%	0.058%
5/6/2021	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	41,222	$3.11M	0.0%	+10.2%	0.023%
5/6/2021	Standard Life Aberdeen plc	19,102	$1.44M	0.0%	+2.2%	0.010%
5/6/2021	M&T Bank Corp	7,158	$0.54M	0.0%	-23.7%	0.004%
5/5/2021	Commerce Bank	7,508	$0.57M	0.0%	+7.4%	0.004%
5/5/2021	TCW Group Inc.	14,882	$1.12M	0.0%	-97.8%	0.008%
5/5/2021	IFM Investors Pty Ltd	20,418	$1.54M	0.0%	+17.3%	0.011%
5/5/2021	Natixis Advisors L.P.	20,064	$1.52M	0.0%	-63.3%	0.011%
5/4/2021	D.B. Root & Company LLC	9,332	$0.70M	0.3%	+33.4%	0.005%
5/4/2021	Griffin Asset Management Inc.	13,650	$1.03M	0.1%	+21.0%	0.008%
5/4/2021	Envestnet Asset Management Inc.	159,427	$12.04M	0.0%	+6.7%	0.088%
5/4/2021	Commonwealth Equity Services LLC	31,470	$2.38M	0.0%	+9.1%	0.017%
5/4/2021	Victory Capital Management Inc.	717,582	$54.19M	0.1%	-3.7%	0.395%
5/3/2021	Great Lakes Advisors LLC	85,692	$6.47M	0.1%	+29.2%	0.047%
5/3/2021	Treasurer of the State of North Carolina	80,598	$6.09M	0.0%	-0.3%	0.044%
5/3/2021	B & T Capital Management DBA Alpha Capital Management	18,260	$1.38M	0.4%	+3.3%	0.010%
5/3/2021	Daiwa Securities Group Inc.	15,262	$1.15M	0.0%	-8.6%	0.008%
5/3/2021	Torray LLC	16,057	$1.21M	0.2%	-75.7%	0.009%
5/3/2021	Zurcher Kantonalbank Zurich Cantonalbank	45,687	$3.45M	0.0%	+19.2%	0.025%
5/3/2021	Raymond James Trust N.A.	3,424	$0.26M	0.0%	-11.4%	0.002%
4/30/2021	MUFG Americas Holdings Corp	16,354	$1.24M	0.0%	+72.5%	0.009%
4/30/2021	Intrua Financial LLC	2,650	$0.21M	0.1%	N/A	0.001%
4/30/2021	Wealthstreet Investment Advisors LLC	26,318	$1.99M	0.2%	-3.0%	0.014%
4/30/2021	Exane Derivatives	2,836	$0.21M	0.1%	+52.6%	0.002%
4/30/2021	IFP Advisors Inc	2,316	$0.18M	0.0%	+13.6%	0.001%
4/30/2021	Stoneridge Investment Partners LLC	5,866	$0.44M	0.2%	N/A	0.003%
4/30/2021	Sumitomo Mitsui Trust Holdings Inc.	586,345	$44.28M	0.0%	-5.0%	0.322%
4/30/2021	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	29,748	$2.25M	0.0%	-2.7%	0.016%
4/29/2021	Handelsbanken Fonder AB	42,771	$3.23M	0.0%	-1.0%	0.024%
4/28/2021	NN Investment Partners Holdings N.V.	35,624	$2.69M	0.0%	+1.9%	0.020%
4/28/2021	US Bancorp DE	28,051	$2.12M	0.0%	-48.6%	0.015%
4/28/2021	DekaBank Deutsche Girozentrale	273,732	$20.49M	0.1%	+7.1%	0.151%
4/28/2021	Comerica Bank	26,409	$2.08M	0.0%	-2.2%	0.015%
4/28/2021	Manning & Napier Group LLC	1,704,842	$128.73M	1.1%	+57.4%	0.938%
4/28/2021	Pegasus Asset Management Inc.	22,310	$1.69M	0.9%	+10.6%	0.012%
4/27/2021	Janney Montgomery Scott LLC	25,054	$1.89M	0.0%	+4.9%	0.014%
4/27/2021	State of New Jersey Common Pension Fund D	112,119	$8.47M	0.0%	-5.8%	0.062%
4/27/2021	Crumly & Associates Inc.	7,538	$0.57M	0.3%	+84.2%	0.004%
4/26/2021	Nisa Investment Advisors LLC	20,630	$1.56M	0.0%	+1.5%	0.011%
4/23/2021	Fieldpoint Private Securities LLC	1,895	$0.14M	0.0%	-21.8%	0.001%
4/23/2021	Robeco Institutional Asset Management B.V.	13,325	$1.01M	0.0%	-50.0%	0.007%
4/23/2021	Strs Ohio	24,912	$1.88M	0.0%	-1.7%	0.014%
4/23/2021	Arden Trust Co	4,345	$0.33M	0.1%	-14.6%	0.002%
4/22/2021	Quattro Financial Advisors LLC	12,000	$0.96M	0.2%	N/A	0.007%
4/22/2021	IBM Retirement Fund	6,138	$0.46M	0.0%	-8.2%	0.003%
4/22/2021	Grandfield & Dodd LLC	11,519	$0.87M	0.1%	+2.5%	0.006%
4/21/2021	Ingalls & Snyder LLC	9,115	$0.69M	0.0%	-14.6%	0.005%
4/21/2021	BOKF NA	14,214	$1.07M	0.0%	+2.4%	0.008%
4/20/2021	MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH	5,203	$0.39M	0.0%	N/A	0.003%
4/20/2021	Exchange Traded Concepts LLC	27,548	$2.08M	0.1%	+66.6%	0.015%
4/19/2021	Appleton Partners Inc. MA	3,425	$0.26M	0.0%	-27.0%	0.002%
4/19/2021	CMH Wealth Management LLC	33,992	$2.57M	1.0%	+2.7%	0.019%
4/19/2021	Guild Investment Management Inc.	9,500	$0.72M	0.8%	+6.6%	0.005%
4/16/2021	Harbor Investment Advisory LLC	2,412	$0.18M	0.0%	+231.8%	0.001%
4/16/2021	NEXT Financial Group Inc	1,016	$77K	0.0%	N/A	0.001%
4/16/2021	Clarus Group Inc.	100,000	$0.30M	0.2%	N/A	0.055%
4/15/2021	Rothschild Investment Corp IL	14,798	$1.12M	0.1%	+1.4%	0.008%
4/15/2021	DnB Asset Management AS	68,147	$5.15M	0.0%	+16.6%	0.037%
4/15/2021	Inspirion Wealth Advisors LLC	5,054	$0.38M	0.1%	N/A	0.003%
4/14/2021	Gateway Investment Advisers LLC	10,165	$0.77M	0.0%	-1.6%	0.006%
4/14/2021	Westside Investment Management Inc.	3,870	$6.33M	0.0%	+975.0%	0.002%
4/14/2021	AdvisorNet Financial Inc	5,726	$0.43M	0.0%	+18.8%	0.003%
4/12/2021	Valeo Financial Advisors LLC	4,123	$0.31M	0.0%	-3.5%	0.002%
4/9/2021	Scout Investments Inc.	480,377	$36.27M	0.5%	+58.3%	0.264%
4/9/2021	NuWave Investment Management LLC	2,444	$0.19M	0.2%	+550.0%	0.001%
4/5/2021	Pacer Advisors Inc.	1,019	$77K	0.0%	-38.8%	0.001%
4/5/2021	Fulton Bank N.A.	3,839	$0.29M	0.0%	+11.9%	0.002%
3/12/2021	DekaBank Deutsche Girozentrale	255,601	$22.05M	0.1%	+1.4%	0.141%
3/8/2021	B. Metzler seel. Sohn & Co. Holding AG	25,387	$2.21M	0.0%	N/A	0.014%
3/8/2021	Teachers Retirement System of The State of Kentucky	226,753	$19.88M	0.2%	+23.9%	0.125%
3/8/2021	Dimensional Fund Advisors LP	428,296	$37.56M	0.0%	+0.9%	0.236%
3/5/2021	Jackson Square Capital LLC	4,124	$0.36M	0.1%	N/A	0.002%
3/4/2021	Eaton Vance Management	18,018	$1.58M	0.0%	+3.2%	0.010%
3/2/2021	Norges Bank	1,449,496	$127.11M	0.0%	N/A	0.798%
3/2/2021	Capital Asset Advisory Services LLC	2,116	$0.19M	0.0%	N/A	0.001%
3/1/2021	UBS Asset Management Americas Inc.	2,462,265	$215.92M	0.1%	+22.0%	1.356%
3/1/2021	Healthcare of Ontario Pension Plan Trust Fund	978	$86K	0.0%	N/A	0.001%
2/25/2021	Dimensional Fund Advisors LP	428,296	$37.56M	0.0%	+0.9%	0.236%
2/24/2021	Alyeska Investment Group L.P.	51,888	$4.55M	0.1%	-77.2%	0.029%
2/24/2021	Bank Julius Baer & Co. Ltd Zurich	14,049	$1.23M	0.0%	+92.4%	0.008%
2/23/2021	Principal Financial Group Inc.	58,777	$5.15M	0.0%	+27.4%	0.032%

Data available starting January 2016

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Aldurazyme to treat mucopolysaccharidosis I, a genetic disease; Brineura for the treatment of late infantile neuronal ceroid lipofuscinosis type 2, a form of Batten disease; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with mucopolysaccharidosis VI; Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme for adult patients with PKU; and Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis IV Type A, a lysosomal storage disorder. In addition, it develops valoctocogene roxaparvovec, an adeno associated virus vector, which is in Phase III clinical trial for the treatment of patients with severe hemophilia A; vosoritide that is in Phase III clinical trial for the treatment of achondroplasia, a form of disproportionate short stature in humans; BMN 307, an AAV5 mediated gene therapy, which is in phase 1/2 clinical trial to normalize blood Phe concentration levels in patients with PKU; BMN 331 for the treatment of hereditary angioedema; BMN 255 for the treatment of chronic renal disease; and BMN 351 for the treatment of Duchenne Muscular Dystrophy. The company has collaboration and license agreements with Sarepta Therapeutics, Asubio Pharma Co., Ltd., and DiNAQOR AG. The company serves specialty pharmacies, hospitals, and foreign government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. It has collaboration with Allen Institute. BioMarin Pharmaceutical Inc. was incorporated in 1996 and is headquartered in San Rafael, California.

Today's Range

Now: $77.77

$77.07

$79.83

50 Day Range

MA: $77.95

$74.73

$81.16

52 Week Range

Now: $77.77

$71.35

$131.95

Volume

628,868 shs

Average Volume

1,215,506 shs

Market Capitalization

$14.21 billion

P/E Ratio

17.80

Dividend Yield

N/A

Beta

0.71

Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top insider shareholders include:

Jean Jacques Bienaime (CEO)
Henry J Fuchs (Insider)
Richard A Meier (Director)
George Eric Davis (EVP)
Jeffrey Robert Ajer (EVP)
Michael G Grey (Director)
Brian Mueller (CFO)
David E I Pyott (Director)
V Bryan Lawlis (Director)
Willard H Dere (Director)

Who are the major institutional investors of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top institutional investors include:

Parnassus Investments CA — 1.47%
Manning & Napier Group LLC — 0.94%
Victory Capital Management Inc. — 0.39%
Swiss National Bank — 0.38%
Sumitomo Mitsui Trust Holdings Inc. — 0.32%
Scout Investments Inc. — 0.26%

Which major investors are selling BioMarin Pharmaceutical stock?

During the previous quarter, BMRN stock was sold by these institutional investors:

TCW Group Inc.
Alliancebernstein L.P.
Torray LLC
Natixis Advisors L.P.
Sumitomo Mitsui Trust Holdings Inc.
Victory Capital Management Inc.
US Bancorp DE
Robeco Institutional Asset Management B.V.

During the previous year, company insiders that have sold BioMarin Pharmaceutical company stock include:

Jean Jacques Bienaime (CEO)
Henry J Fuchs (Insider)
Richard A Meier (Director)
George Eric Davis (EVP)
Jeffrey Robert Ajer (EVP)
Michael G Grey (Director)
Brian Mueller (CFO)
David E I Pyott (Director)
V Bryan Lawlis (Director)

Which major investors are buying BioMarin Pharmaceutical stock?

During the last quarter, BMRN stock was bought by institutional investors including:

Parnassus Investments CA
Manning & Napier Group LLC
Scout Investments Inc.
Clarus Group Inc.
Clarus Group Inc.
Keybank National Association OH
First National Trust Co
Great Lakes Advisors LLC

Hidden $3 Stock Holds Tech World Hostage

From Oxford Club | Ad

Tech monsters like Apple, Amazon, Microsoft and many more can no longer avoid doing business with this one company that trades for only $3...All of them are held hostage by the CEO's brilliant business tactics. He intentionally set up his company's stock under a secret trade name...

Click here to see more.